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Microarray analysis enables the genome-wide detection of copy number variations and
the investigation of chromosomal instability. Whereas array techniques have been well
established for the analysis of unampliﬁed DNA derived from many cells, it has been more
challenging to enable the accurate analysis of single cell genomes. In this review, we pro-
videanoverviewofsinglecellDNAampliﬁcationtechniques,thedifferentarrayapproaches,
and discuss their potential applications to study human embryos.
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INTRODUCTION
Chromosomal abnormalities are inherent to human in vitro fer-
tilized (IVF) preimplantation embryos. FISH studies on normally
developing,goodqualitycleavagestageembryosfromIVFpatients
have shown that 30–65% are aneuploid in at least one cell (Iwars-
son et al., 1999; Munne et al., 2004). A similar proportion of
aneuploidies was detected in embryos derived from normal fer-
tile couples (Rubio et al., 2003; Munne et al., 2004; Baart et al.,
2006). However,aneuploid numbers of locus-speciﬁc FISH probe
signals were in general interpreted as whole-chromosome imbal-
ancestherebyneglectingthepossibilityofstructuralchromosomal
aberrations. It was with the development of metaphase compar-
ative genomic hybridization (CGH) using DOP-ampliﬁed single
cell DNA that the extent of whole-chromosome imbalances could
be probed genome-wide. For the ﬁrst time also segmental chro-
mosomeimbalanceswerereportedinapproximately7–32%of the
embryos (Voullaire et al., 2000, 2002; Wells and Delhanty, 2000;
Wilton, 2005; Daphnis et al., 2008; Rius et al., 2011). Mosaicism
forwhole-chromosomeaneuploidieswasdetectedinupto75%of
human cleavage stage embryos (Wells and Delhanty, 2000; Voul-
laire et al., 2002). With the advent of array CGH, the resolution
for single cell analysis was further increased revealing,in addition
tothewholechromosomalimbalances,segmentalrearrangements
in a large number of embryos (Vanneste et al., 2009a; Voet et al.,
2011).
To provide further insights in the origins of this chromoso-
mal instability as well as for many clinical applications single
cell array approaches will remain invaluable tools in the coming
years. Arrays may complement or replace FISH for preimplan-
tation genetic diagnosis (PGD) and screening (PGS; Alfarawati
et al., 2011; Fiorentino et al., 2011; Vanneste et al., 2011). Finally,
with the advent of genome-wide single nucleotide polymorphism
(SNP) arrays it might also become feasible to use arrays as a tool
to perform PGD in embryos to detect Mendelian disorders (Voet
et al., 2009; Handyside et al., 2010). In this review, we provide an
overview of the different array techniques that have been devel-
oped over the last few years and discuss their possible applications
to study human embryos.
WHOLE GENOME AMPLIFICATION
One cell from an embryo contains approximately 6pg of DNA.
Array methodologies require hundreds of nanograms of input
DNA. Hence, to determine genome-wide copy number varia-
tion within a single cell, whole genome ampliﬁcation (WGA)
is required. WGA approaches can be subdivided into PCR- or
non-PCR-based (isothermal) methods.
A number of PCR-based WGA methods have been developed
including degenerate oligonucleotide primed PCR (DOP-PCR;
Fiegler et al., 2003), primer extension PCR (PEP; Zhang et al.,
1992; Sermon et al., 1996), and ligation-mediated PCR (Saunders
et al., 1989). All those methods suffer from random ampliﬁca-
tion artifacts and incomplete coverage of loci which may result
in the drop out (ADO) or preferential ampliﬁcation (PA) of one
of both alleles (Spits and Sermon, 2009). Recently, a new gen-
eration of PCR-based methods has been developed. Genomeplex
(Sigma-Aldrich,St.Louis,MO63103,USA)andPicoplex/Sureplex
(Rubicon Genomics Inc., MI 48108, USA/BlueGnome Ltd., Mill
Court,GreatShelford,Cambridge,UK)kitsarebaseduponasemi-
random,non-enzymaticfragmentationofgenomicDNAfollowed
bytheadditionofspeciﬁcadaptorsequencestobothends,forming
aninvitro molecularlibrarythatcanbeampliﬁedbyPCRutilizing
ﬂanking universal priming sites. The size of the DNA fragments
rangesfrom100to1000bp,withamediansizeof 400bp.Basedon
the company brochures, an ADO rate of 10% (Picoplex) to 30%
(Genomeplex) can be expected, which is an improvement over
previous PCR-based methods.
Multiple displacement ampliﬁcation (MDA) is a non-
PCR-based isothermal reaction using bacteriophage ϕ29 DNA
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polymerase (Repli-G, Qiagen Inc., Valencia, CA 91355, USA;
GenomiPhi,GE Healthcare,Roosendael,The Netherlands). MDA
is based on a strand displacement ampliﬁcation at constant tem-
perature which results in DNA products of high molecular weight
(up to 70kb;Blanco et al.,1989;Spits et al.,2006a). TheADO rate
of the single cell ampliﬁed loci varies between 0 and 60% (25.8%
on average), while the 25% PA rate was found much more stable
between individual cells (Spits et al.,2006a,b).
In conclusion, a variety of single cell WGA methods are com-
mercially available but none is producing a linear representation
of theoriginalsinglecellgenome.Furthermoretheobtainedarray
results may depend signiﬁcantly on the single cell WGA method
used (see below). ADO or the random loss of alleles can result
in false-positive copy number calls as well as the over- or under-
ampliﬁcation of certain loci in the genome. These ampliﬁcation
artifacts complicate reliable genetic variant deduction from the
signalsobtainedwiththesinglecellWGA-DNAonthemicroarray
platform and require specialized interpretation algorithms.
BAC BASED ARRAY CGH
Array comparative genomic hybridization (aCGH) enables the
detection of gains or losses of DNA in all 24 chromosomes. DNA
fragments with known positions in the genome are immobilized
onaglassslide.Subsequently,DNAfromatestandreferencesam-
ple are differentially labeled and hybridized onto the slides. Copy
number changes are determined by differences in hybridization
intensities between test and reference DNA. The resolution of the
array depends on the size of the probes and the distance between
the probes in the genome. With bacterial artiﬁcial chromosomal
(BAC) based aCGH, BAC DNA fragments are immobilized on a
glass surface. Each clone contains a known chromosomal locus
of about 100–300kb (Oostlander et al., 2004). Besides the home-
made BAC arrays provided by several laboratories (Le Caignec
et al., 2006; Fiegler et al., 2007) at least two BAC arrays are
currently commercially available: (1) the constitutional Chip 4.0
(Perkin Elmer) is comprised of approximately 5000 BAC clones
andtherebyatheoreticalresolutionof∼600kbisachieved.(2)The
24Sure BAC array (Blue Gnome Ltd., Mill Court, Great Shelford,
Cambridge,UK)contains3000clonesspaced1Mbapartacrossthe
genome. Both commercial platforms have the potential to enable
thedetectionof whole-chromosomeaneuploidiesinsinglecellsin
a 24-h protocol as required in preimplantation genetic testing and
provide custom software tools for copy number variation calling.
VALIDATION OF BAC ARRAYS
Le Caignec et al. (2006) validated a strategy that combined
GenomiPhi MDA ampliﬁcation and a home-made 1Mb resolu-
tion BAC array for single cell analysis. By averaging all intensity
ratios per chromosome across multiple single cell experiments
the chromosome-speciﬁc threshold for variation was determined.
Subsequently,theydemonstratedtheaccuratedetectionoftrisomy
13,18,21 and monosomy X in different aneuploid ﬁbroblast lines
by chromosome average signals that surpass the chromosome-
speciﬁc threshold (Le Caignec et al., 2006). By applying an opti-
mized version of the ampliﬁcation method (GenomiPhiV2) and
a new algorithm the resolution to detect de novo imbalances was
improved to 10Mb, when combined with SNP-array technology
(Vanneste et al., 2009a; Konings et al., 2012). The mixture model
that was used not only allowed the calculation of BAC-probe
speciﬁc copy number probabilities, but also provided a quality
assessment allowing the exclusion of un-interpretable single cell
WGA-samples(Vannesteetal.,2009a;Koningsetal.,2012).Fiegler
et al. (2007) developed a home-made tilling BAC array (26,574
clones) which enabled both the detection of aneuploidies and a de
novo deletion of 8.3Mb in GenomePlex ampliﬁed HCT116 single
cells. To detect segmental imbalances, the average intensity ratio
across 10 clones was calculated for each chromosome and plotted
against the midpoint position of the 10 clones used for analysis.
Eachaverageddatapointwasthenfurthernormalized.Substantial
gains and losses comprised at least three consecutive data points
1.5 times above or below the estimate of the experimental vari-
ability. Cells from a renal carcinoma,a colorectal tumor,a trisomy
21, and from a Prader–Willi microdeletion cell line were used
for validation. A false-negative rate of 3.0% was reported, while
the false-positive rate was estimated between 2 and 3% (Fiegler
et al., 2007). Gutierrez-Mateo et al. (2011) used the 24Sure BAC
array (Blue Gnome Ltd., Mill Court, Great Shelford, Cambridge,
UK) following Sureplex ampliﬁcation for cleavage stage embryo
genomecopynumberproﬁling.However,athoroughvalidationis
lacking.Sensitivityandspeciﬁcityof singlecellDNAcopynumber
typingmustbeevaluatedusingasetofcelllineswithknownDNA-
imbalances as exempliﬁed by Fiegler et al. (2006),Vermeesch et al.
(2007),Vanneste et al. (2009a), and Konings et al. (2012).
CLINICAL USE OF BAC ARRAYS
Theﬁrstuseof BACaCGH(followingGenomiPhiV2WGAampli-
ﬁcation)inPGDwasfortheselectionofunbalancedchromosomes
in embryos derived from a patient carrying a complex chromoso-
mal rearrangement (Vanneste et al., 2011). Based on the analysis
of 16 embryos, the sensitivity was 100%, while the speciﬁcity was
89% (Vanneste et al., 2011). At the same time, Alfarawati et al.
(2011) described the ﬁrst clinical application of BAC array-based
screeningappliedtopolarbodies,blastomeres,andtrophectoderm
cells from patients carrying chromosome rearrangements. They
simultaneously screened for unbalanced translocation derivatives
and aneuploidy of all 24 chromosomes. They used the Sureplex
WGAtogetherwiththe24sureVersion2.0orCytochipVersion3.0
BlueGnome arrays (BlueGnome Ltd., Mill Court, Great Shelford,
Cambridge, UK). A total of 16 couples received genetic diagno-
sis of their embryos in 20 cycles (Alfarawati et al., 2011). The
reported diagnostic efﬁciency was 91.5% (Alfarawati et al., 2011).
Fiorentino et al. (2011) used the same set-up and technology in
cleavage stage embryos. Finally, Fishel et al. (2010) reported the
birth of the ﬁrst baby after genome-wide aneuploidy screening
using single cell microarray technology and polar body biopsy.
Overall,thosestudieslackvalidation(Fisheletal.,2010;Alfarawati
et al.,2011; Fiorentino et al.,2011).
OLIGONUCLEOTIDE ARRAYS
The oligonucleotide aCGH procedure is similar to that of BAC
arrays. The ﬁrst arrays contained 44.000 (Agilent Technologies,
Inc., Santa Clara, CA, USA) to 72.000 oligo probes (Nimble-
gen, Roche NimbleGen Systems, Reykjavik, Iceland), while the
latest contain 1–2.1 million targets respectively. Oligonucleotide
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probes contain between 45 and 85 nucleotides. The higher probe
density allows a higher resolution for copy number evaluation.
Moreover,oligonucleotide array construction tends to have a bet-
ter reproducibility and less batch-to-batch variation compared to
BAC arrays (Shearer et al., 2007). The main disadvantage for the
detection of (single cell) chromosomal imbalances is the signiﬁ-
cant noise that becomes more obvious due to the random WGA
artifacts and the higher probe density (Geigl et al., 2009).
VALIDATION OF OLIGO ARRAYS
Geigl et al. (2009) performed GenomePlex ampliﬁed single cell
analyses on high-density oligo tiling arrays including the 380K
(chromosome22),the2.1-M(WholeGenome)Nimblegen(Roche
NimbleGen Systems,Reykjavik,Iceland),and the 240K (Chromo-
some 22) Agilent (Agilent Technologies, Inc., Santa Clara, CA,
USA) arrays. These array analyses revealed that low amounts of
template DNA do not result in a completely unbiased WGA but
thatstochasticampliﬁcationartifactscausesigniﬁcantnoise(Geigl
etal.,2009).Theplatformswerevalidatedusingdifferentcelllines
andanewalgorithmenablingtheidentiﬁcationof smallgainsand
losses in noisy ratio proﬁles was developed. They showed imbal-
ances as small as 3.0Mb could be accurately detected using high
resolutionoligoarraysandconcludedthatprobedensitymayhave
an important impact on the resolution limits (Geigl et al., 2009).
To enhance the resolution further and reduce biases in the single
cellampliﬁcation,wedevelopedasinglechannelbasednormaliza-
tion method to preprocess Agilent 244K human mircroarray data
(Cheng et al., 2011).
CLINICAL USE OF OLIGO ARRAYS
Hellani et al. (2008) reported the birth of the ﬁrst baby after
genome-wide aneuploidy screening of cleavage stage blastomeres
using single cell oligo aCGH. Two blastomeres per biopsied
embryo derived from eight couples suffering recurrent IVF fail-
ures were MDA ampliﬁed and analyzed on the Agilent Human
Genome CGH 44B Oligo Microarray. The DNA from two blas-
tomereswaspooledallowingformorereproducibledata[datanot
shown (Hellani et al., 2008)]. Overall validation of the platform
was limited (Hellani et al.,2008).
SNP ARRAYS
A different type of oligonucleotide arrays are SNP arrays target-
inghundredsof thousandsof SNPs.SinglecellSNP-arrayanalyses
can detect copy number variations and disclose the genotype of
the cell (Iwamoto et al., 2007; Vanneste et al., 2009a). Affymetrix
(Affymetrix Inc.,Santa Clara,CA,USA) and Illumina (San Diego,
CA, USA) provide SNP arrays which differ by the number of
probes and the SNP typing chemistry (such as the ampliﬁcation
technique, the number of color channels, the labeling procedure,
and the time of the procedure).At ﬁrstAffymetrix arrays targeted
only 10,000 SNPs, but in their more recent product this further
improved to 900K SNPs supplemented with 900K copy number
probes (SNP 6.0Array).Affymetrix arrays (Affymetrix Inc.,Santa
Clara, CA, USA) are based on a single color assay which is com-
posedof multipleallele-speciﬁcprobesthatarecomplementaryto
SNPlocipresentinareducedfractionof thegenome.Thereduced
representationof thegenomeisachievedbydigestion,adapterlig-
ation,andPCRampliﬁcation.FollowingPCR-basedampliﬁcation
and fragmentation, the DNA is incorporated with biotin labeled
nucleotides and hybridized onto the array. Following wash and
scan,thesignalintensityisquantiﬁed,andcomparedtointensities
of normal individuals (such as HapMap individuals) in order to
analyze the copy number. The total time for performing the assay
is4days(AffymetrixInc.,SantaClara,CA,USA)1.Illuminaarrays
(San Diego, CA, USA) are based on direct hybridization of whole
genome-ampliﬁed genomic DNA (via a rolling circle replication
mechanism)toabeadarrayof 50merlocus-speciﬁcprobes.These
probesendonenucleotidebeforetheSNP.Followinghybridization
eachSNPisscoredbyasinglebaseextensionassayusingdifferently
labelednucleotides.Theselabelsarevisualizedbystainingwithan
immunohistochemistry assay. For Illumina (San Diego,CA,USA)
the ﬁrst platform contained 317,000 probes and the newest 1 mil-
lion SNP targets. The total time for performing the assay is 3days
(Illumina San Diego, CA, USA)2,h o w e v e rJohnson et al. (2010)
published a 24-h protocol.
VALIDATION OF SNP ARRAYS
Iwamoto and co-workers were the ﬁrst to report single cell SNP-
array analyses for copy number detection using Affymetrix tech-
nology. They showed that variability in single cell ampliﬁcation
bias affected the genotype and copy number analysis of the cell
severely(Iwamotoetal.,2007).Discordantgenotypesweremainly
localizedclosetocentromeresortelomeres(Iwamotoetal.,2007).
Single cell test WGA-samples could be successfully corrected for
insufﬁciently ampliﬁed DNA regions by using both non-WGA
and single cell WGA products as a reference for SNP-copy num-
ber calling (Iwamoto et al., 2007). Treff et al. (2011a) compared
the PCR-based GenomePlex with the isothermal GenomiPhi and
Repli-g MDA–WGA reaction for ampliﬁcation reliability, ﬁdelity
and accuracy using the 250K NspI Affymetrix SNP microarray.
The average genotyping coverage was 74% for GenomiPhi and
78% for Genomeplex, which where both signiﬁcantly lower than
the 88% obtained using Repli-g (Treff et al., 2011a). In our labo-
ratory,an average coverage of 72% via the GenomiPhiV2 method
was measured on the 250K NspI Affymetrix SNP (Vanneste et al.,
2009a). Signiﬁcant differences in the accuracy and copy num-
ber assignment exist amongst different single cell WGA methods
(Treff et al., 2010, 2011a). Using the CNAT software (Affymetrix,
Santa Clara, CA, USA) for single cell SNP-copy number typing,
62% of the SNPs had a match with the copy number proﬁle of
the genomic DNA sample extracted from many cells when the
GenomiPhi method for single cell WGA was used. Copy number
concordances of 95 and 99% were reached on the same SNP-
platform when single cell genomes were ampliﬁed with Repli-G
(Qiagen Inc.,Valencia,CA 91355,USA) and GenomePlex (Sigma-
Aldrich, St. Louis, MO 63103, USA) respectively (Treff et al.,
2011a). Johnson et al. (2010) developed a new method for PGS,
termed “parental support” which uses Illumina SNP microarray
(CytoSNP-12 chips, San Diego, CA, USA) measurements from
parental DNA to “clean” single cell microarray measurements on
embryonic cells and explicitly computes conﬁdence in each copy
number call. A false-negative rate of 2.1% and a false-positive
1www.affymetrix.com
2www.illumina.com
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rate of 3.9% for copy number detection were estimated
(Johnson et al., 2010). To detect segmental copy number aberra-
tions their algorithm was applied to segments spanning one-ﬁfth
of a chromosome, limiting the ability to detect segmental abnor-
malities (Johnson et al., 2010). Handyside et al. (2010) developed
amethodenablinggenome-widelinkage-basedinheritanceanaly-
sis of a broad range of genetic abnormalities including structural
chromosomalabnormalities,DNAcopynumbervariantsaswellas
singlegenedefectsidentiﬁedaspre-existinginoneorbothparents
using the Illumina Human CNV370 Inﬁnium-II Quad and duo.
Theydemonstratedthatkaryomappingispossibleatthesinglecell
level following MDA (Repli-G, Qiagen Inc., Valencia, CA 91355,
USA) if only heterozygous informative loci are used (Handyside
et al., 2010). We developed a novel algorithm that determines the
allelicoriginof (aberrant)locibyidentifyingandvisualizingSNPs
withaMendelianerrorinaparent-speciﬁcmanneratthegenome-
widelevel(Voetetal.,2011).Therefore,wegenotypedbothparents
andthesingleblastomeresusingAffymetrix250KSNParrays(Voet
et al.,2011).
CLINICAL USE OF SNP ARRAYS
Schoolcraft et al. (2010) presented the ﬁrst clinical application
of blastocyst trophectoderm biopsy followed by SNP microar-
ray based 24 chromosome aneuploidy screening, applied to 132
cases with advanced maternal age, recurrent pregnancy loss, or
recurrent implantation failure. They achieved a clinical preg-
nancy rate of 77.8% (Schoolcraft et al., 2010). A case study
by Brezina et al. (2011) reported the birth of a healthy child
after combination of PGD using DNA sequencing, PCR link-
age analysis for GM1 gangliosidosis mutations, and 23 chromo-
some aneuploidy detection following trophectoderm biopsy. For
the aneuploidy screening they used MDA–WGA and Inﬁnium
high-density HumanCytoSNP-12 DNA analysis BeadChips (Illu-
mina, San Diego, CA, USA). Treff et al. (2011b) presented a
clinical prospective study using SNP-array-based translocation
and 24 chromosome aneuploidy screening following trophecto-
derm biopsy. They ﬁrst validated the ability to detect a priori
knownsegmentalaneusomiesassociatedwithunbalancedtranslo-
cation inheritance. To this end, cells of FISH diagnosed unbal-
anced embryos were ampliﬁed by the GenomePlex WGA (Sigma-
Aldrich, St. Louis, MO 63103, USA) and analyzed on the 250K
NspI SNP array (Affymetrix Inc., Santa Clara, CA, USA). They
proved segmental aneusomies as small as 13.8Mb with as few as
908 SNP-probes could be identiﬁed in a single blastomere (Treff
et al.,2011b).
CONCLUSION AND FUTURE PROSPECTIVES
The genome-wide detection of aneuploidies and segmental chro-
mosomal imbalances in single cells can be accurately achieved by
different array approaches. The accuracy has been established for
different array platforms and the technologies are widely used to
study human embryos. Nevertheless, the resolution remains well
below the resolution obtained when using unampliﬁed DNA on
the same platforms. Further improvements in the resolution as
well as the accuracy of single cell analyses are likely to come from
further improvements inWGA methods,array platform design as
well as algorithmic improvements.
Besides fundamental research questions, the main application
of single cell array analysis in the clinic is PGD. PGD is typi-
callyperformedonembryosfromcarriersof monogenicdisorders
or carriers of chromosomal rearrangements affecting the fertil-
ity (such as translocations or marker chromosomes). Currently
chromosomalabnormalitiesareselectedagainstusingFISH,while
monogenic disorders are diagnosed via PCR. Recently, single cell
arraytechniqueshavebeenclinicallyimplementedforPGDaswell
(Fishel et al., 2010; Alfarawati et al., 2011; Fiorentino et al., 2011;
Treff et al., 2011b; Vanneste et al., 2011). Single cell microarray
analysis could be envisioned as a novel generic diagnostic tool for
PGD because it: (1) covers all 24 chromosomes, (2) makes the
interpretation of the results more objective, and (3) excludes the
family speciﬁc preparation compared to the current techniques.
InadditiontoPGD,PGSmaybetheprimeclinicalapplication.
PGS is based on the hypothesis that selection of chromosoma-
lly normal embryos for uterine transfer can increase the live birth
rateanddecreasethespontaneousabortionrateperembryotrans-
ferred. Single cell array analysis allows genome-wide screening of
de novo whole-chromosome and segmental imbalances in 24h
and can be performed on polar bodies,blastomeres,or trophecto-
derm cells. The widespread acceptance for PGS,however,will rely
ontheclinicalvalidation,i.e.,thatthisscreeningleadstoincreased
baby-take-home-rates(Vannesteetal.,2009b;Geraedtsetal.,2010;
Harper et al.,2010a). The application of this technology is rapidly
increasing (Harper et al., 2010b).
Whereas single cell BAC- and oligoarrays can be used to detect
chromosomal imbalances, single cell SNP arrays may be used to
ﬁnd Mendelian disorders. The ability to genotype and haplotype
single cells using SNP arrays has opened new avenues of single
cell research. First,determining the haplotypes can strengthen the
powerandthusincreasetheresolutionofsinglecellCNVdetection
(Vannesteetal.,2009a;Voetetal.,2011).Extractingthehaplotypes
enables the analysis of cross-over sites and the identiﬁcation of
copynumberneutralabnormalitiessuchassegmentaluniparental
disomy(UPD)aswellaslongcontiguousstretchesof homozygous
SNPs (Kotzot,2008).When parental genotypes are known as well,
transmission of haplotypes can be measured. Simple haplotyp-
ing of SNPs surrounding and embedded in disease-causing genes
allow the selection of embryos that have not inherited the affected
risk allele (Harper and Harton, 2010). Genome-wide genotyping,
may thus allow the selective transfer of genetically and chromoso-
mally normal embryos for patients undergoing IVF with PGD for
monogenic diseases (Handyside et al., 2010).
Tounderstandthechromosomalinstabilityinhumanembryos
it may well be necessary to go beyond the inherent limitations
of array CGH. With the strongly reduced costs of whole genome
sequencing, those sequencing technologies offer the promise to
further increase the resolution and provide the ultimate genomic
architectural view of single cells for basic genome research pur-
poses. It seems likely that the picture of human embryonic
instability will become more complete in the years to come.
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